RE-BVS – Piemonte Repository

Sfoglia per AUTORE
STELLATO M
Collezione AO Ordine Mauriziano

Items : 9

Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial. in European urology / Eur Urol. 2023 Jan;83(1):82-89. doi: 10.1016/j.eururo.2022.09.025. Epub 2022 Oct 8.

2023
AO Ordine Mauriziano

Procopio G; Lolli C; Di Napoli M; Pignata S; Ignazzi G; Gamba T; Veccia A; Scandurra G; Hamzaj A; Ermacora P; Masini C; Aieta M; Atzori F; Stellato M; Carella C; Bimbatti D; Giannatempo P; De Giorgi U; Vignani F; Tambaro R; Pierantoni F; Zonno A; Santini D; Di Maio M;

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No

2022
AO Ordine Mauriziano

Procopio G; De Braud FG; Verzoni E; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Roviello G; Buttigliero C; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Casadei C; Santini D; Buti S; De Giorgi U; Bimbatti D; Di Maio M; Mennitto A; Zattarin E;

Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group). in Immunotherapy / Immunotherapy. 2022 Feb;14(2):107-114. doi: 10.2217/imt-2021-0109. Epub 2021 Nov 17.

2022
AO Ordine Mauriziano

Procopio G; Losanno T; Naglieri E; Stellato M; Tambaro R; Banna GL; Vignani F; De Giorgi U; Basso U; Maruzzo M; Farè E; Raggi D; Giannatempo P; Mazzaschi G; Bersanelli M; Pignata S; Necchi A; Buti S;

Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2022 Apr;20(2):155-164. doi: 10.1016/j.clgc.2021.12.008. Epub 2021 Dec 16.

2022
AO Ordine Mauriziano

Calabrò F; Losanno T; Caffo O; Veccia A; Roviello G; Vignani F; Santini D; Stellato M; Bersanelli M; Buti S; Naglieri E; Casadei C; De Giorgi U; Banna GL; Lipari H; Maruzzo M; Pierantoni F; Marandino L; Giannatempo P; Raggi D; Mucciarini C; Pignata S; Necchi A; Maio MD;

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The ?-Meet-URO analysis. in Frontiers in oncology / Front Oncol. 2022 Sep 23;12:955501. doi: 10.3389/fonc.2022.955501. eCollection 2022.

2022
ASL Cuneo 2
AO Ordine Mauriziano

Nolè F; Prati G; Morelli F; Messina M; Caffo O; Di Napoli M; Atzori F; Soto Parra HJ; Prati V; Cortellini A; Sorarù M; Santoni M; Massari F; Panni S; Ricotta R; Sabbatini R; Fratino L; Boccardo F; Milella M; Procopio G; Carella C; Fantinel E; Zucali PA; Galli L; Pedrazzoli P; De Giorgi U; Maruzzo M; Santini D; Stellato M; et alii...

Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7). in American journal of clinical oncology / Am J Clin Oncol. 2021 Mar 1;44(3):121-125. doi: 10.1097/COC.0000000000000791.

2021
AO Ordine Mauriziano

Mini E; Grillone F; Mucciarini C; Fornarini G; Soraru' M; Verzoni E; Sbrana A; Di Lorenzo G; De Vivo R; Bersanelli M; Buti S; Naglieri E; Bimbatti D; Maruzzo M; Casadei C; De Lisi D; Pantano F; De Giorgi U; Stellato M; Santini D; Vignani F; Attademo L; Pignata S; Procopio G;

Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b). in Frontiers in oncology / Front Oncol. 2021 Jun 8;11:682449. doi: 10.3389/fonc.2021.682449. eCollection 2021.

2021
AO Ordine Mauriziano

Mucciarini C; Vignani F; De Vivo R; Napolitano A; Buti S; Naglieri E; Di Lorenzo G; Soraru M; Sbrana A; Maruzzo M; Fornarini G; Casadei C; Pantano F; De Giorgi U; Verzoni E; Santini D; Stellato M; Grillone F; Roviello G; Di Napoli M; Procopio G;

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 May 18;13:17588359211019642. doi: 10.1177/17588359211019642. eCollection 20

2021
AO Ordine Mauriziano

Bersanelli M; Casadei C; Pierantoni F; Roviello G; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Messina C; Messina M; Pignata S; Atzori F; Stellato M; Soto Parra HJ; Prati V; Santoni M; Cortellini A; Sorarù M; Mollica V; Panni S; Ricotta R; Baldessari C; Fratino L; Tomasello L; Merler S; Procopio G; Naglieri E; Masini C; et alii...

Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study). in American journal of clinical oncology / Am J Clin Oncol. 2020 Sep;43(9):621-627. doi: 10.1097/COC.0000000000000719.

2020
AO Ordine Mauriziano

Sepe P; Martinetti A; Mennitto A; Verzoni E; Claps M; Raimondi A; Sottotetti E; Grassi P; Guadalupi V; Stellato M; Zattarin E; Di Maio M; Procopio G;